Hearing Aid Education and Adaptation System
Launched by HEALTHCARE TECHNOLOGIES AND METHODS, LLC · Jul 20, 2016
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
HTM will develop the "TELLYHealth (tm) system" that will provide education on hearing aid use and maintenance. HTM will conduct a randomized controlled trial (RCT) to quantify the benefits of TELLYHealth to patients and audiologists including: reductions in hearing handicap, improved knowledge of hearing aid handling, use and communications strategies; and improved audiologist aftercare. The investigators will recruit 80 subjects (half in each group) and each subject will participate in the study for 8-12 weeks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Speaks and reads English fluently
- • Has mild (25-40 dB) to severe (70-95 dB) monaural sensorineural hearing loss
- • Will be fitted with one or two hearing aids at the time of enrollment
- • Owns a standard TV
- • Has Internet access at home
- • Has sufficient corrected vision to watch videos and read text on the TV and mobile device
- • No signs of dementia
- Exclusion Criteria:
- • Lives with person who has enrolled in the study
About Healthcare Technologies And Methods, Llc
Healthcare Technologies and Methods, LLC is a pioneering clinical trial sponsor dedicated to advancing medical research through innovative healthcare solutions. Specializing in the development and application of cutting-edge technologies and methodologies, the company focuses on enhancing trial design, improving patient outcomes, and streamlining processes. With a commitment to scientific rigor and regulatory compliance, Healthcare Technologies and Methods, LLC collaborates with researchers, healthcare providers, and industry partners to facilitate the successful execution of clinical trials across various therapeutic areas, ultimately contributing to the advancement of healthcare and improved quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Rockville, Maryland, United States
Patients applied
Trial Officials
Alan M Letzt, M.S.
Principal Investigator
Healthcare Technologies and Methods, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials